Clinical Trial

Feasibility of a Deep Learning-based Algorithm for Non-invasive Assessment of Vulnerable Coronary Plaque

Study acronym: FOCUS DL
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 7, 2025 (before its estimated June 2025 completion). Its status may not reflect the trial's current state.
Summary
The primary objective of this study is to assess the accuracy in terms of sensitivity, specificity, negative and positive predicted values of the DL-based algorithm with respect to correct identification of the plaque and associated vulnerability grade.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-12-15; most recent amendment 2025-01-06.
Trial Details
NCT Number NCT06186336
Lead Sponsor GE Healthcare
Collaborators: Azienda Socio-Sanitaria Territoriale di Pavia
Conditions Chronic Coronary Syndrome, Coronary Artery Disease, Stable Angina, Acute Coronary Syndrome
Enrollment 200 participants
Start Date 2025-01
Primary Completion 2025-06 (estimated)
Study Completion 2025-06 (estimated)
Updated on ClinicalTrials.gov 2025-01-07